Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Splenectomy during chronic lymphocytic leukemia.

B Pegourie, J J Sotto, D Hollard

    Cancer
    |May 1, 1987
    PubMed
    Summary

    High-dose chlorambucil therapy combined with splenectomy significantly improves outcomes for aggressive chronic lymphocytic leukemia (CLL). This treatment approach offers extended survival and potential clone elimination in patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Chronic disseminated candidiasis and acute leukemia: Impact on survival and hematopoietic stem cell transplantation agenda.

    Medecine et maladies infectieuses·2018
    Same author

    Outcome of Frontline Treatment with "Generic" Imatinib In Adult Patients with Chronic Myeloid Leukemia in Algerian Population: A Multicenter Study.

    Mediterranean journal of hematology and infectious diseases·2017
    Same author

    Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT.

    Journal of internal medicine·2017
    Same author

    How to prevent relapse after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia and myelodysplastic syndrome.

    Current research in translational medicine·2017
    Same author

    Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients.

    Leukemia·2017
    Same author

    Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord.

    Bone marrow transplantation·2017

    Area of Science:

    • Hematology
    • Oncology
    • Clinical Medicine

    Background:

    • Chronic lymphocytic leukemia (CLL) is a heterogeneous lymphoid malignancy.
    • Aggressive forms of CLL often present a poor prognosis.
    • Treatment strategies for advanced CLL require continuous evaluation.

    Purpose of the Study:

    • To evaluate the efficacy of combining discontinuous high-dose chlorambucil with splenectomy in aggressive CLL.
    • To assess the impact of this combined therapy on patient survival and disease progression.

    Main Methods:

    • Retrospective analysis of 43 patients with aggressive CLL treated with chlorambucil and splenectomy.
    • Survival data analyzed from diagnosis and post-splenectomy.
    • Splenic infiltration patterns (nodular vs. diffuse) were correlated with outcomes.

    Main Results:

    • Median survival was 84 months from diagnosis and 48 months post-splenectomy.
    • Patients with nodular splenic infiltration had a longer median survival (104 months) than those with diffuse infiltration (72 months).
    • Complete disappearance of the lymphocytic clone was observed in 4 out of 15 cases post-splenectomy.

    Conclusions:

    • The combination of high-dose chlorambucil and splenectomy offers a significant survival benefit for aggressive CLL.
    • Splenic involvement patterns may predict treatment response and prognosis.
    • This therapeutic strategy can lead to molecular remission in a subset of patients.

    Related Experiment Videos